Nieuwe inzichten helpen patiënt in strijd tegen depressie Siemens Healthineers Nederland
Prof. Dr. Ron van Schaik (PhD, FACB) is a registered European Specialist Laboratory Medicine and a Full Professor of Pharmacogenetics. He is working at the Dept. Clinical Chemistry at the Erasmus University Medical Center Rotterdam, and is Director of the International (IFCC) Expert-center for Pharmacogenetics.
Interview Ron van Schaik
Pharmacogenetics International Expertcenter - Prof. Dr. Ron H.N. van Schaik - Erasmus MC Research group/lab | Prof. Dr. Ron H.N. van Schaik Pharmacogenetics International Expertcenter Research is aimed at discovery and implementation of DNA analysis for personalizing drug therapy About our research group/lab Our research Key Publications
Ronald van Schaik Werf&
Prof. Dr. Ron van Schaik, PhD is a registered European specialist Laboratory medicine (2003) and a Full Professor of Pharmacogenetics (2013). He is working at the Dept. Clinical Chemistry at the Erasmus University Medical Center Rotterdam, The Netherlands.
Prof. Dr. Ron H.N. van Schaik Laboratoriumspecialist Erasmus MC
Prof. Dr. Ron van Schaik studied Chemistry at Utrecht University, with specialisations in Biochemistry, Molecular Biology and Clinical Chemistry. He did his PhD on Molecular cloning and Immunological localization of PLA2 at the Dept. Biochemistry of the Center of Biomembranes and Lipid Research (CBML) at Utrecht University,. A 4 year post-doc at the Dept. Endocrinology, Erasmus MC Rotterdam on.
20171222_10Gold Ron van Schaik Flickr
Ron van Schaik Cytochrome P450 3A4 (CYP3A4) is the most important drug metabolizing enzyme in the liver, responsible for the oxidative metabolism of ∼50% of clinically prescribed drugs.
Ron H van Schaik, Professor, Erasmus University, Rotterdam, the Netherlands (5) YouTube
Ron SCHAIK | Cited by 18,852 | of Erasmus MC, Rotterdam (Erasmus MC) | Read 541 publications | Contact Ron SCHAIK
Interview Ronald van Schaik (Kaliber) op The Social Conference 2017 YouTube
Prof van Schaik has given over 200 invited lectures and participates on multiple national and international advisory committees on pharmacogenetics In 2001, he received the Ortho Clinical Diagnostics Award for Outstanding Research, in 2009 the AACC Outstanding Speaker Award, and in 2010 the AACC/Mol Pathology Award for Outstanding Scientific Research.
Ron van Schaik Associate Professor Erasmus MC XING
Dive into the research topics where Ron van Schaik is active. These topic labels come from the works of this person. Together they form a unique fingerprint. 1 Similar Profiles; Circulating Tumor DNA Medicine & Life Sciences 100%. Cytochrome P-450 CYP2D6 Medicine & Life Sciences 87%.
Faculty of Pharmaceutical Sciences Ron van Schaik, PhD Michael Smith Laboratories
Andrews, Louise ; Hesselink, Dennis; van Schaik, Ron et al. / A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients.In: British Journal of Clinical Pharmacology. 2019 ; Vol. 85, No. 3. pp. 601-615.
Ron van Schaik • BioTech Pharma Summit
Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study. ML Becker, LE Visser, RHN van Schaik, A Hofman, AG Uitterlinden,. Diabetes 58 (3), 745-749. , 2009. 313.
Ron H van Schaik, Professor, Erasmus University, Rotterdam, the Netherlands (3) YouTube
Prof. Dr. Ron van Schaik is hoogleraar Farmacogenetica, en leidt het Internationaal Expertise-laboratorium Farmacogenetica van de Afd. Klinische Chemie. Focus is implementatie van farmacogenetica. Wetenschappelijk onderzoek richt zich op de Oncologie (PGx en ctDNA analyses), Psychiatrie, Transplantatie en de Pijnbestrijding (opioiden.
Forward Thinking An Interview with Ron Van Schaik PMF Features
Simple Summary Although the introduction of programmed cell death 1 (PD-1) immune checkpoint inhibitors (ICIs) has significantly improved the overall survival (OS) in patients with metastatic.
Ron SCHAIK Professor Erasmus MC, Rotterdam Erasmus MC Department of Clinical Chemistry (AKC)
New insights were provided by the esteemed keynote speakers, André G. Uitterlinden, Ron H.N. van Schaik, Roos van Westrhenen and all other speakers, Lone Fisker, Jordan Moore, Tiffany Morris, PhD.
Interview Ron van Schaik
Contact External Profile About Introduction Publications Other positions Profile of R.H.N. van Schaik, PhD, Erasmus MC, Rotterdam, Professor Pharmacogenetics.
20181103_19Wintersun Ron van Schaik Flickr
31 okt. 2015 Activiteit Je gezondheid begint in je buik. Dat is me wel weer duidelijk geworden. Ik had vandaag een inspirerende eerste dag als directeur-bestuurder van de… Gemarkeerd als.
Interview Prof. Ron H. van Schaik YouTube
Ron H.N. van Schaik's Post Ron H.N. van Schaik Full Professor Pharmacogenetics / Head Dept Clinical Chemistry / Past-President European Society Pharmacogenomics & Personalised Therapy (ESPT)